These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Scientometrics of drug discovery efforts: pain-related molecular targets. Kissin I Drug Des Devel Ther; 2015; 9():3393-404. PubMed ID: 26170624 [TBL] [Abstract][Full Text] [Related]
8. New molecules for the treatment of pain. Heinzmann S; McMahon SB Curr Opin Support Palliat Care; 2011 Jun; 5(2):111-5. PubMed ID: 21455071 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and Personalized Medicine in Pain Management. Webster LR; Belfer I Clin Lab Med; 2016 Sep; 36(3):493-506. PubMed ID: 27514464 [TBL] [Abstract][Full Text] [Related]
10. Functional genomics of pain in analgesic drug development and therapy. Lötsch J; Doehring A; Mogil JS; Arndt T; Geisslinger G; Ultsch A Pharmacol Ther; 2013 Jul; 139(1):60-70. PubMed ID: 23567662 [TBL] [Abstract][Full Text] [Related]
11. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors. Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics in pain management: the clinical need. Webster LR Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063 [TBL] [Abstract][Full Text] [Related]
13. Analgesic Effects Mediated by Muscarinic Receptors: Mechanisms and Pharmacological Approaches. De Angelis F; Tata AM Cent Nerv Syst Agents Med Chem; 2016; 16(3):218-226. PubMed ID: 26931765 [TBL] [Abstract][Full Text] [Related]
14. Biological pathways and genetic variables involved in pain. Shi Q; Cleeland CS; Klepstad P; Miaskowski C; Pedersen NL; Qual Life Res; 2010 Dec; 19(10):1407-17. PubMed ID: 20842532 [TBL] [Abstract][Full Text] [Related]
15. Interpreting patient treatment response in analgesic clinical trials: implications for genotyping, phenotyping, and personalized pain treatment. Dworkin RH; McDermott MP; Farrar JT; O'Connor AB; Senn S Pain; 2014 Mar; 155(3):457-460. PubMed ID: 24071599 [No Abstract] [Full Text] [Related]
16. Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity. Capsoni S; Covaceuszach S; Marinelli S; Ceci M; Bernardo A; Minghetti L; Ugolini G; Pavone F; Cattaneo A PLoS One; 2011 Feb; 6(2):e17321. PubMed ID: 21387003 [TBL] [Abstract][Full Text] [Related]
17. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Mogil JS Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7744-51. PubMed ID: 10393892 [TBL] [Abstract][Full Text] [Related]
18. Transient receptor potential channels - emerging novel drug targets for the treatment of pain. Sałat K; Moniczewski A; Librowski T Curr Med Chem; 2013; 20(11):1409-36. PubMed ID: 23409716 [TBL] [Abstract][Full Text] [Related]
19. The pharmacogenetics of analgesia: toward a genetically-based approach to pain management. Flores CM; Mogil JS Pharmacogenomics; 2001 Aug; 2(3):177-94. PubMed ID: 11535108 [TBL] [Abstract][Full Text] [Related]
20. The LQT syndromes--current status of molecular mechanisms. Schulze-Bahr E; Wedekind H; Haverkamp W; Borggrefe M; Assmann G; Breithardt G; Funke H Z Kardiol; 1999 Apr; 88(4):245-54. PubMed ID: 10408028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]